Ranjit Bindra

Ranjit Bindra

Company: Modifi Bio

Job title: Co-Founder


Exploiting DNA Repair Defects via Direct DNA Modification – A New Paradigm in Oncology Drug Development 3:45 pm

Overview of DNA modifiers (DMs) and how they can be engineered to exploit DDR defects Strategies to evade known drug resistance pathways using DMs Potential for combination therapies with DMsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.